167
Views
6
CrossRef citations to date
0
Altmetric
Review Article

Rising occurrence of hypocitraturia and hyperoxaluria associated with increasing prevalence of stone disease in calcium kidney stone formers

, , , , , , & show all
Pages 426-430 | Received 15 May 2020, Accepted 08 Jul 2020, Published online: 27 Jul 2020

References

  • Scales CD Jr., Smith AC, Hanley JM, et al. Prevalence of kidney stones in the United States. Eur Urol. 2012;62(1):160–165.
  • Raheem OA, Khandwala YS, Sur RL, et al. Burden of urolithiasis: trends in prevalence, treatments, and costs. Eur Urol Focus. 2017;3(1):18–26.
  • Antonelli JA, Maalouf NM, Pearle MS, et al. Use of the National Health and Nutrition Examination Survey to calculate the impact of obesity and diabetes on cost and prevalence of urolithiasis in 2030. Eur Urol. 2014;66(4):724–729.
  • Stamatelou KK, Francis ME, Jones CA, et al. Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int. 2003;63(5):1817–1823.
  • Scales CD Jr., Curtis LH, Norris RD, et al. Changing gender prevalence of stone disease. J Urol. 2007;177(3):979–982.
  • Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005;293(4):455–462.
  • Semins MJ, Shore AD, Makary MA, et al. The association of increasing body mass index and kidney stone disease. J Urol. 2010;183(2):571–575.
  • Kohjimoto Y, Sasaki Y, Iguchi M, et al. Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan. Am J Kidney Dis. 2013;61(6):923–929.
  • Maalouf NM, Sakhaee K, Parks JH, et al. Association of urinary pH with body weight in nephrolithiasis. Kidney Int. 2004;65(4):1422–1425.
  • Abate N, Chandalia M, Cabo-Chan AV Jr., et al. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int. 2004;65(2):386–392.
  • Brikowski TH, Lotan Y, Pearle MS. Climate-related increase in the prevalence of urolithiasis in the United States. Proc Natl Acad Sci USA. 2008;105(28):9841–9846.
  • Penniston KL, McLaren ID, Greenlee RT, et al. Urolithiasis in a rural Wisconsin population from 1992 to 2008: narrowing of the male-to-female ratio. J Urol. 2011;185(5):1731–1736.
  • Strope SA, Wolf JS, Jr., Hollenbeck BK. Changes in gender distribution of urinary stone disease. Urology. 2010;75(3):543–546.
  • Xu LHR, Adams-Huet B, Poindexter JR, et al. Temporal changes in kidney stone composition and in risk factors predisposing to stone formation. J Urol. 2017;197(6):1465–1471.
  • Kittanamongkolchai W, Vaughan LE, Enders FT, et al. The Changing Incidence and Presentation of Urinary Stones Over 3 Decades. Mayo Clin Proc. 2018;93(3):291–299.
  • Roudakova K, Monga M. The evolving epidemiology of stone disease. Indian J Urol. 2014;30(1):44–48.
  • Maalouf NM, Sato AH, Welch BJ, et al. Postmenopausal hormone use and the risk of nephrolithiasis: results from the women's health initiative hormone therapy trials. Arch Intern Med. 2010;170(18):1678–1685.
  • Maalouf NM, Cameron MA, Moe OW, et al. Low urine pH: a novel feature of the metabolic syndrome. Clin J Am Soc Nephrol. 2007;2(5):883–888.
  • Pak CY, Sakhaee K, Moe O, et al. Biochemical profile of stone-forming patients with diabetes mellitus. Urology. 2003;61(3):523–527.
  • Sorensen MD, Chi T, Shara NM, et al. Activity, energy intake, obesity, and the risk of incident kidney stones in postmenopausal women: a report from the women's health initiative. JASN. 2014;25(2):362–369.
  • Knoll T, Schubert AB, Fahlenkamp D, et al. Urolithiasis through the ages: data on more than 200,000 urinary stone analyses. J Urol. 2011;185(4):1304–1311.
  • Lieske JC, Rule AD, Krambeck AE, et al. Stone composition as a function of age and sex. CJASN. 2014;9(12):2141–2146.
  • Krambeck AE, Lieske JC, Li X, et al. Effect of age on the clinical presentation of incident symptomatic urolithiasis in the general population. J Urol. 2013;189(1):158–164.
  • Sas DJ. An update on the changing epidemiology and metabolic risk factors in pediatric kidney stone disease. Clin J Am Soc Nephrol. 2011;6(8):2062–2068.
  • Zuckerman JM, Assimos DG. Hypocitraturia: pathophysiology and medical management. Rev Urol. 2009;11(3):134–144.
  • Astroza GM, Neisius A, Tsivian M, et al. Treatment response in patients with stones, and low urinary ph and hypocitraturia stratified by body mass index. J Urol. 2016;195(3):653–657.
  • Spradling K, Vernez SL, Khoyliar C, et al. Prevalence of hyperoxaluria in urinary stone formers: chronological and geographical trends and a literature review. J Endourol. 2016;30(4):469–475.
  • Sakhaee K. Unraveling the mechanisms of obesity-induced hyperoxaluria. Kidney Int. 2018;93(5):1038–1040.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.